Pfizer Consumer Healthcare acquired Alacer Corp. (Emergen-C). Note: borderline consumer health rather than pharma; included for completeness given Pfizer's broader 2011 consumer-health roll-up. May be excluded by reviewer per consumer-health rule.
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Financial impact
Neutral
Pipeline outcome
Assets Advanced
Assessment window: 10yr post-close.
Key facts
AnnouncedApr 11, 2011
ClosedFeb 01, 2012
Deal typeAcquisition/Merger
Therapeutic areaConsumer health / dietary supplement